Active Partnership for Expansion and Progress

Priveq invests in unlisted growth companies. Our aim is to invest in unique companies rather than specific sectors; a goal-oriented management team is more important than belonging to any particular sector.

Companies that attract Priveq’s interest normally have sales of over SEK 100 m and can demonstrate profitable growth.


Read more about our business 
News
23/04/2010
Priveq Investment awarded the Swedish Venture Capital Association's Prize for the Exit of the Year

14/01/2010
Priveq closes most successful exit ever in Swedish Orphan International

From our portfolio

Carmel Pharma AB is the world leader in closed drug transfer systems for handling of toxic drugs such as cytostatics and antibiotics. The company product system is named PhaSeal® and was introduced on the Swedish market in 1994. Since the start in Sweden, many millions of doses of hazardous drugs have been given with PhaSeal® protecting health c...

Read more 


PRIVEQ INVESTMENT | Box 5295, SE-102 46 Stockholm, Sweden | Visitors: Riddargatan 17 | Tel: +46 (0)8 459 67 60 | Fax: +46 (0)8 20 35 66 | info@priveq.se